BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29478412)

  • 1. Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.
    Ngo L; Miller E; Valen P; Gertner E
    J Med Case Rep; 2018 Feb; 12(1):48. PubMed ID: 29478412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.
    Gauci ML; Baroudjian B; Laly P; Madelaine I; Da Meda L; Vercellino L; Bagot M; Lioté F; Pages C; Lebbé C
    Semin Arthritis Rheum; 2017 Oct; 47(2):281-287. PubMed ID: 28438383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.
    Bas O; Ozbek A; Guven D; Aktepe O; Kılıc L; Kertmen N; Erman M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1230-1233. PubMed ID: 31735133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome mimicking symptoms of polymyalgia rheumatica: a case report.
    Tarasiuk-Stanislawek K; Dumusc A; Favrat B; Kokkinakis I
    J Med Case Rep; 2022 Aug; 16(1):334. PubMed ID: 36028914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitor-Associated Remitting Seronegative Symmetrical Synovitis With Pitting Edema: Description of a New Entity by CanRIO.
    Rouhi A; Jamal S; Arreola LG; Moon D; Hudson M; Roberts J; Ladouceur A; Ye C
    J Rheumatol; 2024 May; 51(5):523-528. PubMed ID: 38428960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remitting seronegative symmetrical synovitis with pitting edema: a case report.
    Tanaka Y; Kohchi K; Kitamoto K
    J Med Case Rep; 2022 Mar; 16(1):125. PubMed ID: 35331322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.
    Wada N; Uchi H; Furue M
    J Dermatol; 2017 Aug; 44(8):e196-e197. PubMed ID: 28391613
    [No Abstract]   [Full Text] [Related]  

  • 8. Remitting seronegative symmetrical synovitis with pitting edema syndrome complicated with primary lung cancer.
    Matsuoka H; Matsubara H; Sugimura A; Uchida T; Ichihara T; Miyauchi Y; Kondo T; Nakajima H
    Int Cancer Conf J; 2017 Jan; 6(1):16-21. PubMed ID: 31149462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.
    Yanamoto S; Fukae J; Fukiyama Y; Fujioka S; Ouma S; Tsuboi Y
    J Med Case Rep; 2016 Jul; 10():198. PubMed ID: 27439425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remitting Seronegative Symmetric Synovitis With Pitting Edema Associated With Partial Melanoma Response Under Anti-CTLA-4 and Anti-Programmed Death 1 Combination Treatment.
    Amini-Adle M; Piperno M; Tordo J; Thomas L; Dalle S; Dubois V; Marabelle A
    Arthritis Rheumatol; 2018 Aug; 70(8):1358. PubMed ID: 29579372
    [No Abstract]   [Full Text] [Related]  

  • 11. Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis.
    Matsugasumi T; Nakanouchi T; Mikami K; Shiraishi T; Kadoya M; Toriyama S; Taniguchi H; Fujihara A; Hongo F; Ukimura O
    IJU Case Rep; 2020 Nov; 3(6):278-281. PubMed ID: 33163925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: ultrasonography as a diagnostic tool.
    Agarwal V; Dabra AK; Kaur R; Sachdev A; Singh R
    Clin Rheumatol; 2005 Sep; 24(5):476-9. PubMed ID: 15856369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remitting seronegative symmetrical synovitis with pitting edema: a review.
    Lakhmalla M; Dahiya DS; Kichloo A; Fatima T; Edigin E; Wani F
    J Investig Med; 2021 Jan; 69(1):86-90. PubMed ID: 33122249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual case of remitting seronegative symmetrical synovitis with pitting edema: Case report and literature review.
    Joseph AD; Kumanan T; Aravinthan N; Suganthan N
    SAGE Open Med Case Rep; 2020; 8():2050313X20910920. PubMed ID: 32215210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome).
    Hung SC; Kung YY; Lin HY
    J Formos Med Assoc; 1999 Jul; 98(7):516-8. PubMed ID: 10463003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remitting seronegative symmetrical synovitis with pitting edema syndrome postsecond COVID-19 vaccination: a case report.
    Hodifa Y; Khalayli N; Hodaifa A; Kudsi M
    Ann Med Surg (Lond); 2023 Aug; 85(8):4118-4120. PubMed ID: 37554915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remitting seronegative symmetrical synovitis with pitting edema following acute intracranial hemorrhage.
    Yang DH; Chang DM; Lai JH; Huang GS; Chang WC; Hou TY
    Rheumatol Int; 2011 Jan; 31(1):101-4. PubMed ID: 19826822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndrome precedes the onset of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome.
    Matsunaga T; Izumi Y; Iwanaga N; Kawahara C; Shigemitsu Y; Yoshida S; Kawakami A; Ogawa D; Migita K
    Tohoku J Exp Med; 2015 Jan; 235(1):47-52. PubMed ID: 25744363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema.
    Redman JM; Rhea LP; Cordes L; Owens H; Madan RA; Bilusic M; Gulley JL; Lee JM; Dahut WL; Karzai F
    Clin Genitourin Cancer; 2019 Jun; 17(3):e549-e552. PubMed ID: 30850338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Remitting Seronegative Symmetrical Synovitis with Pitting Edema associated with Lung Malignancy:Case Report and Literature Review].
    Huang J; Meng HY; Wang LJ; He BX; Xu HW; Zhou L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):149-152. PubMed ID: 33663677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.